The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.
Imhoff, the team's Diabetes/Endocrinology, Kellogg Eye Center, Nephrology and Rheumatology communicator, joined Michigan Medicine in 2019. She's passionate about storytelling and brand activism. Twitter: @JordynImhoff
In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.
Research finds COVID-19 associated with mental health problems after discharge, with majority not recognizing significant symptoms as a concern.
No more finger pricks: a continuous glucose monitor benefits patients with diabetes in more ways than one
For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.